Adaptive Biotechnologies Corp (ADPT) has issued an update.
Adaptive Biotechnologies Corporation has appointed Kyle Piskel as its new Chief Financial Officer, effective April 8, 2024. Piskel will earn an annual salary of $380,000, with the potential for a 40% bonus based on performance goals. He’ll receive a restricted stock unit grant of 31,260 shares, a performance stock unit grant of 75,000 shares, and an additional annual equity refresh of 43,740 restricted stock units. His stock grants come with specific vesting schedules and performance conditions, and he’ll be eligible for the same severance benefits as other Executive Vice Presidents, in addition to standard company benefits.
Find detailed analytics on ADPT stock on TipRanks’ Stock Analysis page.
